CAGE PHARMACEUTICALS, INC.

Profile

Company Names

CAGE PHARMACEUTICALS, INC.

Addresses

512 W. 22ND STREET, 5TH FLOOR, NEW YORK, NY 10011

500 E. PRATT STREET, SUITE 1200, BALTIMORE, MD 21202

Phone Numbers

917-832-1832
917-733-1542

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$967,490.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-05-01 
$137,490.00 
$137,490.00 
$0.00 
Equity 
2
2019-07-10 
$480,000.00 
$480,000.00 
$0.00 
Equity 
1
2017-12-22 
$350,000.00 
$1,700,000.00 
$1,350,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
MALIK 
DIRECTOR
CAGE PHARMACEUTICALS, INC.
PETER 
 
OLAGUNJU 
EXECUTIVE OFFICER, DIRECTOR
CAGE PHARMACEUTICALS, INC.   |  MARCH BIOSCIENCES, INC.
NICK 
 
PAPADOPOULOS 
DIRECTOR
PAPGENE, INC.   |  CAGE PHARMACEUTICALS, INC.
JASON 
 
RIFKIN 
EXECUTIVE OFFICER
CAGE PHARMACEUTICALS, INC.   |  EPISTEME PROGNOSTICS, INC.
ISAAC 
 
RO 
DIRECTOR
HAYSTACK ONCOLOGY, INC.   |  PINKDX, INC.   |  CAGE PHARMACEUTICALS, INC.   |  PROGNOMIQ, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-31
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-01 
2019-07-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-10 
2018-01-05
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#